“Deucravacitinib in Plaque Psoriasis: 2-Year Laboratory Results from the Phase 3 POETYK PSO Program”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s119. https://doi.org/10.25251/skin.7.supp.119.